Longbow Research lowers its rating for Apple shares to neutral from buy, predicting it will ship less iPhones than expected this year. » Read More
By: Keris Lahiff
Scott Redler of T3Live.com called oil's comeback. Now, he says crude could rise 22 percent more this year. » Read More
By: Tae Kim
Bank of America Merrill Lynch reiterates its buy rating and raises its price target to $220 from $180 for Apple shares. » Read More
Despite all the hype, volumes and open interest have been fairly small in Cboe and CME bitcoin contracts.
Celgene is in talks to buy biotechnology company Juno Therapeutics, The Wall Street Journal reported.
The U.S. government could shut down later this week and that could spell trouble for investors in the near term, history shows.
Jim Cramer gave investors several key guidelines for maneuvering the bull market in beast mode.
Amplify ETFs CEO Christian Magoon thinks investing in blockchain now, will bring returns as big as those from today's FAANG companies.
Jim Cramer examined the tech titans' weekly stock charts to determine if it's time for investors to take some profits.
Jim Cramer listed the J.P. Morgan's Healthcare Conference's best and worst performers judging by the stock market's reaction.
Jim Cramer said there’s one thing that this market needs to do to curb the major stock shortage facing investors.
The e-commerce giant has risen every trading day so far this year. For two analysts, the streak isn't over yet.
A good start to the year is only going to get better for J.P. Morgan Chase, according to veteran banking analyst Dick Bove.
Don't mistake affability for financial savvy — the investment seller may be a con man.
Komal Sri-Kumar sees a continued short-term rise in the stock market with "a much sharper fall at some point in time."
Kovacevich says he believes bitcoin is a scam. "It makes no sense. I'm just surprised it isn't even lower."
The company issued strong yearly guidance citing efforts to close Apple litigation and an NXP acquisition.
A trade war between the U.S. and China is "the number 1 risk and also the number 2 and number 3 risk," Jim Cramer argues.
Some of the names on the move ahead of the open.
Get the best of CNBC in your inbox